# Repurposing Alzheimer’s disease medications—systemic cholinesterase inhibitors—for the treatment of dry eye syndrome, glaucoma, and age-related macular degeneration

**Authors:** Shilpa Rajagopal, Pranati Ahuja, Valerie Quach, Cody Luong, Mukaila A. Raji

PMC · DOI: 10.1177/25158414251341022 · Therapeutic Advances in Ophthalmology · 2025-05-16

## Full-text entities

- **Diseases:** dry eye syndrome (MESH:D015352), glaucoma (MESH:D005901), age-related macular degeneration (MESH:D008268), Alzheimer's disease (MESH:D000544)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12084700/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12084700/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12084700/full.md

---
Source: https://tomesphere.com/paper/PMC12084700